Neuronetics
$21.029876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$21.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.85 (+15.47%) Today
-$0.25 (-1.18%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Neuronetics and other stocks, options, and ETFs commission-free!
About STIM
Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA. The listed name for STIM is Neuronetics, Inc. Common Stock.
CEO
Keith J. Sullivan
Employees
235
Headquarters
Malvern, Pennsylvania
Founded
2001
Market Cap
363.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
664.99K
High Today
$22.39
Low Today
$18.59
Open Price
$18.90
Volume
2.03M
52 Week High
$22.43
52 Week Low
$1.25
Collections
STIM Earnings
-$0.68
-$0.45
-$0.23
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 2, After Hours